Phase II trial of metronomic treatment in children and adolescents with recurrent or progressive neuroblastoma
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/12/2013 - 30/11/2017
Description
Keywords: progressive neuroblastoma
Funding identifier: METRO-NB2012
Funder / funding scheme:
- Deutsche Kinderkrebsstiftung e.V.
Project management at the University of Münster
| Faldum, Andreas | Institute of Biostatistics and Clinical Research (IBKF) |
Applicants from the University of Münster
| Faldum, Andreas | Institute of Biostatistics and Clinical Research (IBKF) |
Research associates from the University of Münster
| Schmidt, Rene | Institute of Biostatistics and Clinical Research (IBKF) |